Dr. Ron Vender debates the possibility of AI replacing dermatologists at WCD2023 in Singapore.

Dr. Ron Vender reviews the safety of deucravacitinib in Asian patients at WCD2023 in Singapore.

Dr. Ron Vender reviews a poster about deucravacitinib.

Dr. Ron Vender reviews the TYK2 inhibitor deucravacitinib at WCD2023 in Singapore.

Dr. Ron Vender discusses JAK and TYK2 inhibitors at WCD2023 in Singapore.

Patients with moderate-to-severe plaque psoriasis have lower fertility rates and higher risk of pregnancy loss than women with psoriasis.

Dr. Ron Vender discusses the late breaking study of an oral peptide to treat moderate-to-severe psoriasis at WCD2023 in Singapore.

Dr. Ron Vender summarizes a presentation about AI and digital dermatology at WCD2023 in Singapore.